VRISE THERAPEUTICS INC.
VRise is a precision oncology company pursuing ground-breaking discovery and development of novel small molecules. VRise uses a proprietary discovery engine to target pathways that determine cancer growth, proliferation and differentiation.
VRISE THERAPEUTICS INC.
Industry:
Biopharma Biotechnology Life Science Oncology Pharmaceutical
Founded:
2021-08-10
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vrisetx.com
Total Employee:
11+
Status:
Active
Contact:
+1 617 4305303
Email Addresses:
[email protected]
Technology used in webpage:
ReCAPTCHA Indian Server Location
Similar Organizations
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
EpiVario
EpiVario develops novel compounds to treat memory-related psychiatric disorders at the source of the disease.
Iroko Pharmaceuticals
Iroko Pharmaceuticals is a global specialty pharmaceutical company dedicated to advancing the science of analgesia.
Navrogen
Navrogen is a biopharmaceutical company focused on the targeted treatment of cancer.
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Halo Labs
Halo Labs is a biotechnology company that specializes in analytical instrumentation and biopharma.
Pinpoint Therapeutics
Pinpoint Therapeutics is a preclinical stage company developing novel cancer treatment options aimed to specifically inhibit autophagy.
PRUNUS Therapeutics
PRUNUS Therapeutics is a preclinical stage immuno-oncology startup focusing on innovative small molecules.
Teal Omics
Teal Omics is a biotechnology company building an AI-enabled proteomics platform to discover novel targets of aging and age-related disease.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.vrisetx.com
- Host name: 216.10.252.35
- IP address: 216.10.252.35
- Location: India
- Latitude: 20.0063
- Longitude: 77.006
- Timezone: Asia/Kolkata
More informations about "VRise Therapeutics Inc."
About Us โ Vrise TX
[email protected]; About Us; Science; Pipeline; News; Contact; Our Leadership. VRise Therapeutics was founded with the goal to bring transformative change to the lives of cancer patients. We have assembled a seasoned management โฆSee details»
VRise Therapeutics Inc. - Crunchbase Company Profile & Funding
Organization. VRise Therapeutics Inc. Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +1 โฆSee details»
VRise Therapeutics, Inc. | LinkedIn
VRise Therapeutics is a global biotechnology company, which aspires to bring transformative change to the lives of cancer patients, through precision medicine ...See details»
Our Science - Vrise TX
[email protected]; About Us; Science; Pipeline; News; Contact; Our Science. Pioneering Discovery Of Novel Therapeutics. VRise is a precision oncology company pursuing ground-breaking discovery and development of novel small โฆSee details»
Vrise Therapeutics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Vrise Therapeutics Inc. of Cambridge, MA. Get the latest business insights from Dun & Bradstreet.See details»
VRise Expands Scientific Advisory Board with the Addition of โฆ
Jun 30, 2023 For more information about VRise Therapeutics, visit www.vrisetx.com. Forward Looking Statements. This press release contains forward-looking statements regarding the โฆSee details»
VRise Therapeutics - Work in biotech
VRise Therapeutics is a precision oncology company developing small molecule drugs to target cancer growth, proliferation, and differentiation pathways. Their focus on biomarker-driven โฆSee details»
VRise Therapeutics, Inc. announces scientific presentations at the ...
For more information about VRise Therapeutics, visit us at www.vrisetx.com or follow us on LinkedIn. Forward Looking Statements This press release contains forward-looking statements โฆSee details»
Terms and Conditions โ Vrise TX
Welcome to https://vrisetx.com/! These terms and conditions outline the rules and regulations for the use of VRise Therapeutics, Inc.โs Website, located at info ...See details»
VRise Therapeutics Inc. Appoints Dr. Francesco Bertoni, an Expert ...
Oct 3, 2024 For more information about VRise Therapeutics, Inc., visit www.vrisetx.com. Forward Looking Statements This press release contains forward-looking statements โฆSee details»
VRise Therapeutics Announces Eminent Oncologist Dr. Anthony
Jul 11, 2022 Currently, Dr. Tolcher is founder and CEO of NEXT Oncology, and Director of Clinical Research in San Antonio, TX, U.S.A, a clinical research organization dedicated to โฆSee details»
VRise Therapeutics Inc. Announces Acceptance of Late Breaking โฆ
Oct 15, 2024 For more information about VRise Therapeutics, Inc. and the research being presented, please visit www.vrisetx.com. About the EORTC-NCI-AACR Symposium The 36th โฆSee details»
VRISE THERAPEUTICS, INC. (@IncVrise) / Twitter
Mar 8, 2022 A Precision Medicine Company. #AACR22 Upcoming presentation by Vrise Therapeutics, Inc at AACR Annual conference, 2022 Novel and Selective Inhibitors of โฆSee details»
Pipeline โ Vrise TX
[email protected]; About Us; Science; Pipeline; News; Contact; Our Pipeline. VRTX126: KRAS-G12C Inhibitor. Discovery. Optimization. IND Enabling. Phase I. IND-Tox Ready . Colorectal โฆSee details»
Research programme: KRAS-G12 mutation cancer therapeutics
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»
VRise Therapeutics, Inc. announces scientific presentations at the ...
Mar 8, 2022 VRise Therapeutics, Inc., a precision oncology company, today announced that it is presenting at the upcoming AACR Annual Meeting 2022, April 08-13 at Ernest N.See details»
Vikas Shirsath โ Vrise TX
Vikas Shreekrishna Shirsath is an Entrepreneurial, Scientific, and Passionate leader with 22 years of experience in delivering superior business results in Drug Discovery Innovation and โฆSee details»
Research programme: androgen receptor degraders - VRise โฆ
If your organization has a subscription, there are several access options, even while working remotely: Working within your organizationโs network Login with username/password or try to โฆSee details»
Our News โ Vrise TX
[email protected]; About Us; Science; Pipeline; News; Contact; Our News. NOVEMBER 20, 2024 VRise Therapeutics Inc. Announces Acceptance of Late Breaking Abstract for San Antonio โฆSee details»